Back
Catalyst Pharmaceuticals Vs. IES Holdings Industry Stock Comparison
Buy
55
CPRX
Catalyst Pharmaceuticals
Last Price:
16.50
Seasonality Move:
16.98%
Buy
83
IESC
IES Holdings
Last Price:
159.76
Seasonality Move:
2.77%
Buy
55
Catalyst Pharmaceuticals (CPRX)
is a Buy
Is Catalyst Pharmaceuticals a Buy, Sell or Hold?
- The current Catalyst Pharmaceuticals [CPRX] share price is $16.49. The Score for CPRX is 55, which is 10% above its historic median score of 50, and infers lower risk than normal.
- CPRX is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.
- This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
Buy
83
IES Holdings (IESC)
is a Buy
Is IES Holdings a Buy, Sell or Hold?
- The current IES Holdings [IESC] share price is $159.95. The Score for IESC is 83, which is 66% above its historic median score of 50, and infers lower risk than normal.
- IESC is currently trading in the 80-90% percentile range relative to its historical Stock Score levels.
- This Score is currently showing an extreme reading that indicates risk levels may be considerably lower than normal.
CPRX Stock Price Chart
What is Catalyst Pharmaceuticals's stock price today?
-
The Catalyst Pharmaceuticals share price today is $16.49
Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CPRX is experiencing slight selling pressure.
IESC Stock Price Chart
What is IES Holdings's stock price today?
-
The IES Holdings share price today is $159.95
The current trend is moderately bullish and IESC is experiencing slight selling pressure.
CPRX Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 0.28 | Buy |
| Relative Strength Index (14 RSI): | 61.13 | Buy |
| Chaikin Money Flow: | -382725 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (14.82 - 16.04) | Buy |
| Bollinger Bands (100): | (14.24 - 16.32) | Buy |
IESC Technical Analysis
| Chart Indicators | Level | Buy or Sell |
|---|---|---|
| MACD (12, 26): | 11.99 | Buy |
| Relative Strength Index (14 RSI): | 57.43 | Buy |
| Chaikin Money Flow: | -70049 | - |
| Bollinger Bands | Level | Buy or Sell |
|---|---|---|
| Bollinger Bands (25): | (122.15 - 167.71) | Buy |
| Bollinger Bands (100): | (83.51 - 137.67) | Buy |
CPRX Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 16.07 | Buy |
| 20-day SMA: | 15.42 | Buy |
| 50-day SMA: | 15.68 | Buy |
| 200-day SMA: | 14.37 | Buy |
| 8-day EMA: | 16.14 | Buy |
| 20-day EMA: | 15.73 | Buy |
| 50-day EMA: | 15.49 | Buy |
| 200-day EMA: | 14.73 | Buy |
IESC Moving Averages
| Moving Averages | Level | Buy or Sell |
|---|---|---|
| 8-day SMA: | 170.04 | Sell |
| 20-day SMA: | 151.72 | Buy |
| 50-day SMA: | 130.68 | Buy |
| 200-day SMA: | 89.93 | Buy |
| 8-day EMA: | 164.78 | Sell |
| 20-day EMA: | 154.57 | Buy |
| 50-day EMA: | 135.56 | Buy |
| 200-day EMA: | 96.94 | Buy |
Catalyst Pharmaceuticals Earnings Growth & CPRX Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.02 per share, an increase next quarter of $0.09 per share, a decrease this year of $0.14 per share, and an increase next year of $0.20 per share.
IES Holdings Earnings Growth & IESC Earnings Dates
- Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.
Catalyst Pharmaceuticals Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||
IES Holdings Technical Analysis
| May 6 | May 7 | May 8 | May 9 | May 10 | May 13 | May 14 | May 15 | May 16 | May 17 | |
|---|---|---|---|---|---|---|---|---|---|---|
| May | ||||||||||
| 06 | 07 | 08 | 09 | 10 | 13 | 14 | 15 | 16 | 17 | |
| Technical Analysis: Buy or Sell? | ||||||||||
| 8-day SMA: | ||||||||||
| 20-day SMA: | ||||||||||
| 50-day SMA: | ||||||||||
| 200-day SMA: | ||||||||||
| 8-day EMA: | ||||||||||
| 20-day EMA: | ||||||||||
| 50-day EMA: | ||||||||||
| 200-day EMA: | ||||||||||
| MACD (12, 26): | ||||||||||
| Relative Strength Index (14 RSI): | ||||||||||
| Bollinger Bands (25): | ||||||||||
| Bollinger Bands (100): | ||||||||||